Premier Bionics plans AIM listing
Wednesday, 19 October, 2005
Premier Bionics (ASX:PBI) is seeking to list on London's Alternative Investment Market (AIM).
It is expected that its admission on AIM will take place on or around November 16, with the company's ordinary shares and options continuing to be traded on the ASX.
"The AIM listing is very strategic to us because we're planning Medic Vision's expansion in the UK and Ireland and then ultimately Europe," said Medic Vision CEO Ross Horley.
Medic Vision -- a 100 per cent owned subsidiary of Premier Bionics -- is expanding sales of its virtual reality simulators and skills centre development projects in the UK and European markets.
"As a result we need a good corporate presence in the region, particularly in London."
The dual listing is also expected to give Premier Bionics greater international exposure and the opportunity to gain direct access to UK capital markets.
Premier Bionics has appointed Corporate Synergy as its broker for the listing.
More effective antibiotic found for Lyme disease
Researchers have found that piperacillin, an antibiotic in the same class as penicillin,...
Why do our waistlines expand in middle age?
A new preclinical study highlights the importance of controlling new fat-cell formation to...
Anti-inflammatory drug may help treat alcohol use disorder
A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...
